116 related articles for article (PubMed ID: 8150101)
1. Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas.
Dawood MY; Khan-Dawood FS
Fertil Steril; 1994 Apr; 61(4):617-21. PubMed ID: 8150101
[TBL] [Abstract][Full Text] [Related]
2. [Composite microassays of plasma progesterone, 17alpha-OH-progestrerone, estrone, 17beta-estradiol and estriol in normal adult women. I. Assay methods and steroid patterns in normal menstrual cycle (author's transl)].
Suginami H
Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):908-23. PubMed ID: 1241848
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles.
Wang HS; Lee JD; Soong YK
Fertil Steril; 1995 Jun; 63(6):1204-9. PubMed ID: 7538473
[TBL] [Abstract][Full Text] [Related]
5. Daily follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone in ten women harboring uterine leiomyomas.
Maheux R; Lemay-Turcot L; Lemay A
Fertil Steril; 1986 Aug; 46(2):205-8. PubMed ID: 3089842
[TBL] [Abstract][Full Text] [Related]
6. Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives.
Jernström H; Olsson H
Gynecol Obstet Invest; 1994; 38(4):261-5. PubMed ID: 7851812
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period.
Michaud DS; Manson JE; Spiegelman D; Barbieri RL; Sepkovic DW; Bradlow HL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1059-64. PubMed ID: 10613337
[TBL] [Abstract][Full Text] [Related]
8. Effects of diet supplementation with wheat bran on serum estrogen levels in the follicular and luteal phases of the menstrual cycle.
Rose DP; Lubin M; Connolly JM
Nutrition; 1997 Jun; 13(6):535-9. PubMed ID: 9263234
[TBL] [Abstract][Full Text] [Related]
9. Leiomyomas: steroid receptor content. Variation within normal menstrual cycles.
Soules MR; McCarty KS
Am J Obstet Gynecol; 1982 May; 143(1):6-11. PubMed ID: 7081313
[TBL] [Abstract][Full Text] [Related]
10. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
de Ziegler D; Bergeron C; Cornel C; Medalie DA; Massai MR; Milgrom E; Frydman R; Bouchard P
J Clin Endocrinol Metab; 1992 Feb; 74(2):322-31. PubMed ID: 1730810
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between serum epidermal growth factor and uterine leiomyoma].
Li M; Li B; Niu Z
Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):175-7. PubMed ID: 11775900
[TBL] [Abstract][Full Text] [Related]
12. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
Gelety TJ; Pearlstone AC; Surrey ES
Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
[TBL] [Abstract][Full Text] [Related]
13. [Affect of insulin-like growth factor I and estradiol on the growth of uterine leiomyoma].
Huang J; Zou J; Xu B; Zhang Y; Chen X; Liu D
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):29-32. PubMed ID: 11938733
[TBL] [Abstract][Full Text] [Related]
14. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
[TBL] [Abstract][Full Text] [Related]
15. [Plasma concentration of estrogens and androgens in postmenopausal women with or without endometrial cancer].
Nagasako S; Asanuma N; Nagata Y
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jun; 40(6):707-13. PubMed ID: 3292674
[TBL] [Abstract][Full Text] [Related]
16. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
[TBL] [Abstract][Full Text] [Related]
17. Menstrual cyclicity of CA-125 in patients with endometriosis.
Hornstein MD; Thomas PP; Gleason RE; Barbieri RL
Fertil Steril; 1992 Aug; 58(2):279-83. PubMed ID: 1633891
[TBL] [Abstract][Full Text] [Related]
18. Glycodelin levels in uterine flushings and in plasma of patients with leiomyomas and polyps: implications for implantation.
Richlin SS; Ramachandran S; Shanti A; Murphy AA; Parthasarathy S
Hum Reprod; 2002 Oct; 17(10):2742-7. PubMed ID: 12351556
[TBL] [Abstract][Full Text] [Related]
19. Follicular fluid concentrations of free insulin-like growth factor (IGF)-I during follicular development in mares.
Spicer LJ; Santiago CA; Davidson TR; Bridges TS; Chamberlain CS
Domest Anim Endocrinol; 2005 Nov; 29(4):573-81. PubMed ID: 16213990
[TBL] [Abstract][Full Text] [Related]
20. Growth and obesity and its association with plasma level of steroid hormones and insulin-like growth factor-I (IGF-I) in Slovak female students.
Zatko T; Matejovicova B; Boledovicova M; Vondrakova M; Bezakova A; Sirotkin AV
Bratisl Lek Listy; 2013; 114(10):573-80. PubMed ID: 24156681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
